Pfizer and BioNTech expect to apply for approval from the US Food and Drug Administration (FDA) for their coronavirus vaccine for use in children aged 6 months to 5 years in November, the company’s CFO Frank D’Amelio told an industry conference on Tuesday. Pfizer had … Read More